Literature DB >> 16003318

Interleukin-1beta is prominent in the early pulmonary inflammatory response after hepatic injury.

Sean C Glasgow1, Sabarinathan Ramachandran, Krista A Csontos, Jianluo Jia, Thalachallour Mohanakumar, William C Chapman.   

Abstract

BACKGROUND: Acute lung injury and inflammation can occur after hepatic ischemia/reperfusion or cryoablation. The etiology of this response is uncertain although it involves NF-kappaB-mediated cytokine release from the liver.
METHODS: Inflammation-specific complementary DNA microarrays were utilized to evaluate cytokine upregulation in mouse lung at 4 hours after partial-volume hepatic cryoablation with a recirculating liquid N(2) probe. Hierarchical cluster analysis was performed to identify candidate genes. On the basis of these results, an enzyme-linked immunosorbent assay for interleukin-1beta (IL-1beta) was conducted on serum and pulmonary parenchymal specimens. The time course of IL-1beta transcriptional upregulation in the liver and lungs was evaluated by quantitative reverse transcription/real-time polymerase chain reaction.
RESULTS: Starting with a pool of 35 genes generated from normalization and variation filtration, unsupervised hierarchical clustering clearly distinguished lungs of hepatic cryo-injured mice from controls. Genes from the IL-1-family were prominent in the signature. IL-1beta was demonstrable in serum within 2 hours postinjury (218 +/- 89 pg/mL vs 0 at baseline, P = .01). In the lung, IL-1beta was more than 4-fold greater at 4 hours than at baseline. Real-time polymerase chain reaction showed a transcription peak of IL-1beta at 30 minutes in the liver, whereas expression in the lungs remained low until 60 minutes, then continued to increase through 4 hours.
CONCLUSIONS: Microarray analysis identified cytokines of the IL-1 family as central components of acute lung injury after hepatic cryoablation. IL-1beta levels increased in both serum and lung tissue over 4 hours after liver injury. Expression of IL-1beta peaked early in the injured liver remnant, followed by subsequent increases in the lungs. Targeted intervention against IL-1beta may ameliorate liver-mediated lung injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16003318     DOI: 10.1016/j.surg.2005.03.005

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Reduced-flow ex vivo lung perfusion to rehabilitate lungs donated after circulatory death.

Authors:  Jared P Beller; Matthew R Byler; Dustin T Money; William Z Chancellor; Aimee Zhang; Yunge Zhao; Mark H Stoler; Adishesh K Narahari; Alexander Shannon; J Hunter Mehaffey; Curtis G Tribble; Victor E Laubach; Irving L Kron; Mark E Roeser
Journal:  J Heart Lung Transplant       Date:  2019-09-18       Impact factor: 10.247

2.  Complement depletion enhances pulmonary inflammatory response after liver injury.

Authors:  Sean C Glasgow; Sathyabama Kanakasabai; Sabarinathan Ramachandran; T Mohanakumar; William C Chapman
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

Review 3.  Lung injury following acute kidney injury: kidney-lung crosstalk.

Authors:  Kent Doi; Tomoko Ishizu; Toshiro Fujita; Eisei Noiri
Journal:  Clin Exp Nephrol       Date:  2011-06-01       Impact factor: 2.801

4.  Pre-conditioning cryosurgery: cellular and molecular mechanisms and dynamics of TNF-α enhanced cryotherapy in an in vivo prostate cancer model system.

Authors:  Jing Jiang; Raghav Goel; Stephen Schmechel; Gregory Vercellotti; Colleen Forster; John Bischof
Journal:  Cryobiology       Date:  2010-10-20       Impact factor: 2.487

Review 5.  The effects of apigenin administration on the inhibition of inflammatory responses and oxidative stress in the lung injury models: a systematic review and meta-analysis of preclinical evidence.

Authors:  Ali Rahimi; Mina Alimohammadi; Fatemeh Faramarzi; Reza Alizadeh-Navaei; Alireza Rafiei
Journal:  Inflammopharmacology       Date:  2022-06-04       Impact factor: 5.093

6.  Alterations in the proteome of pulmonary alveolar type II cells in the rat after hepatic ischemia-reperfusion.

Authors:  Jan Hirsch; Claus U Niemann; Kirk C Hansen; SooJinNa Choi; Xiao Su; James A Frank; Xiaohui Fang; Ryutaro Hirose; Pierre Theodore; Anil Sapru; Alma L Burlingame; Michael A Matthay
Journal:  Crit Care Med       Date:  2008-06       Impact factor: 7.598

7.  Mast cell stabilization alleviates acute lung injury after orthotopic autologous liver transplantation in rats by downregulating inflammation.

Authors:  Ailan Zhang; Xinjin Chi; Gangjian Luo; Ziqing Hei; Hua Xia; Chenfang Luo; Yanling Wang; Xiaowen Mao; Zhengyuan Xia
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

8.  The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.

Authors:  Anders S I Andreasson; Lee A Borthwick; Colin Gillespie; Kasim Jiwa; Jonathan Scott; Paul Henderson; Jonny Mayes; Rosalba Romano; Marius Roman; Simi Ali; James E Fildes; Nandor Marczin; John H Dark; Andrew J Fisher
Journal:  J Heart Lung Transplant       Date:  2017-05-12       Impact factor: 10.247

9.  TLR4 as receptor for HMGB1-mediated acute lung injury after liver ischemia/reperfusion injury.

Authors:  Zhongwei Yang; Yuxiao Deng; Diansan Su; Jie Tian; Yuan Gao; Zhengyu He; Xiangrui Wang
Journal:  Lab Invest       Date:  2013-04-29       Impact factor: 5.662

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.